Predictive Value of Infarction Volume on Hemorrhagic Transformation in Ischemic Stroke/TIA With Non-valve Atrial Fibrillation(NVAF) Patients Using Rivaroxaban
Last updated on July 2021Recruitment
- Recruitment Status
- Recruiting
- Estimated Enrollment
- Same as current
Summary
- Conditions
- Anticoagulant
- Cerebrovascular Stroke
- Intracranial Hemorrhages
- Matrix Metalloproteinases
- Type
- Observational
- Design
- Observational Model: CohortTime Perspective: Prospective
Participation Requirements
- Age
- Between 18 years and 125 years
- Gender
- Both males and females
Description
Not Provided
Not Provided
Tracking Information
- NCT #
- NCT03772457
- Collaborators
- Bayer
- Investigators
- Study Chair: Min Lou, PhD Second Affiliated Hospital, School of Medicine, Zhejiang University